Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Clinical trial NCT06594172 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06594172
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2025-12-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.